We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,952.00
Bid: 11,952.00
Ask: 11,956.00
Change: 600.00 (5.29%)
Spread: 4.00 (0.033%)
Open: 11,890.00
High: 12,086.00
Low: 11,790.00
Prev. Close: 11,352.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: boohoo Latest To Snap Up Arcadia Brands

Mon, 08th Feb 2021 07:49

(Alliance News) - Stock prices in London were seen opening higher on Monday, with optimism over a US stimulus package offsetting concerns about the AstraZeneca and Oxford University Covid-19 vaccine.

IG futures indicate the FTSE 100 index is to open 30.2 points higher at 6,519.53. The blue-chip index closed down 0.2%, or 14.39 points at 6,489.33 on Friday.

In early corporate news on Monday, Experian said it is continuing a "detailed forensic investigation" following a Brazilian data leak, but noted that evidence suggests its technology systems have not been compromised.

Among mid-caps, Electrocomponents posted improved revenue for the four-months to January 31 and Drax unveiled a sizeable Canadian acquisition.

AIM-listed online retailer boohoo Group has forked out just over GBP25 million for the e-commerce and digital assets of Burton, Dorothy Perkins and Wallis, three Arcadia Group brands.

Equity markets rallied early on Monday with Asian stocks soaring and London futures in positive territory, despite "significant bad vaccine news over the weekend", analysts at Danske Bank noted.

"A new study suggests that AstraZeneca has only limited efficacy versus the South African variant, at least for mild diseases," Danske Bank analysts said.

South Africa has temporarily suspended the AstraZeneca and Oxford University jab against a new variant found in the country, according to the health department and top local scientists.

The AstraZeneca-Oxford vaccine protects against the original Covid-19 strain, but its efficacy drops off substantially when it comes to the new variant called B.1.351 or 501.V2, raising serious concerns, said Shabir Madhi, the professor of vaccinology at the University of the Witwatersrand, citing a new local study involving 2,000 participants.

Danske Bank analysts also noted the "expectations for a significant fiscal stimulus package from US".

US President Joe Biden seized on feeble US employment data, published on Friday, to argue the world's largest economy needs his USD1.9 trillion pandemic relief package, which cleared a key Senate hurdle without support from the Republican opposition.

"I believe the American people are looking right now to their government for help," Biden said after a meeting with top Democratic lawmakers. "So I'm going to act. I'm going to act fast."

Back in the UK, Rolls-Royce is planning to shut down its jet engine factories this summer due to insufficient work, the Telegraph reported on Saturday.

According to the newspaper, this is a first time Roll-Royce has done this and results from what Rolls-Royce described as a "significantly reduced" workload resulting from the Covid-19 pandemic.

The two-week closures, focused around its headquarters in Derby, will affect all of the 19,000 staff within Rolls-Royce's civil aerospace division, including 12,500 UK staff, who make airliner jet engines.

On Monday, boohoo joined online peer ASOS in snapping up retail brands from the failed Arcadia Group.

boohoo will buy the e-commerce and digital assets and associated intellectual property rights of Burton, Dorothy Perkins and Wallis for GBP25.2 million from Arcadia's joint-administrators.

"This is a great acquisition for the group as we extend our market share across a broader demographic, capitalising on growth opportunities as more and more customers shop online. We continue to grow our portfolio of brands and customer base, strengthening our position as a leader in global fashion e-commerce," boohoo Executive Chair Mahmud Kamani said.

The deal does not include any stores, however.

Philip Green's Arcadia Group went under back in November, putting 13,000 jobs at risk.

The UK high street continues to suffer from restrictions to control Covid-19. Like Arcadia Group, department store chain Debenhams also sunk into administration.

boohoo in January announced a deal for all of the intellectual property assets of Debenhams Retail for GBP55 million in cash.

Credit checking firm Experian noted that "data which is being illegally offered for sale on the internet, some of which may have been sourced from Serasa's non-sensitive marketing data". Serasa is a Brazilian unit owned by Experian. Like its parent, Serasa provides credit granting and validation services.

Experian said it is "continuing to carry out a detailed forensic investigation".

So far, the company explained, it knows that data offered includes photographs, social media logins, vehicles registrations, and "social security INSS", the latter concerning social security contributions in Brazil.

Experian however, noted that this data is not collected by Serasa.

"There is no evidence that positive or negative credit data has been illegally obtained from Serasa," the company said. "In spite of exhaustive investigations to date there is no evidence that our technology systems have been compromised."

In the FTSE 250, Electrocomponents posted improved revenue over the past four months, but noted "heightened freight, labour and logistical costs".

Revenue in the four months ended January 31 was up 8% annually on a life-for-like basis. In the second quarter to September, like-for-like revenue had fallen 4%. In the first-quarter ended June, it plunged 11%.

The distributor of industrial and electronic products left its annual profit outlook unchanged, "with stronger revenue growth offset by additional ongoing costs".

"The heightened freight, labour and logistical costs we are experiencing are likely to persist at a time of ongoing investment in our proposition. Despite these pressures, our confidence in our strategy remains strong," Electrocomponents said.

Power station operator Drax Group said it plans to bolster its Canadian unit with the purchase of Pinnacle Renewable Energy.

It will acquire Pinnacle at CAD11.30 per share, valuing the renewables firm's fully diluted equity at CAD385 million, about GBP226 million. The sum implies an enterprise value of CAD741 million.

Drax added: "The acquisition, which remains subject to Drax and Pinnacle shareholder approval, court approval, regulatory approvals and the satisfaction of certain other customary conditions, has been unanimously recommended by the board of Pinnacle and has the full support of Pinnacle's major shareholder, affiliates of ONCAP."

ONCAP holds about 31% of Pinnacle's shares, Drax noted.

Elsewhere in London, a regulatory filing showed Mike Ashley's Frasers Group sold its entire 24.93% stake in French Connection Group in a transaction on Thursday.

French Connection on Friday noted it received two separate takeover approaches. The proposals were from Spotlight Brands in conjunction with Gordon Brothers International and from Go Global Retail in conjunction with HMJ International Services.

Sterling was trading at USD1.3730 on Monday morning, largely flat from USD1.3728 at the London equities close on Friday.

The euro stood at USD1.2036 on Monday morning London time, up from USD1.2025 at the European equities close on Friday. Against the yen, the dollar was trading at JPY105.51, improved from JPY105.45 at the London market close on Friday.

The Japanese Nikkei 225 index jumped 2.2% on Monday, closing above the 29,000-point mark. In China, the Shanghai Composite closed 1.0% higher, while the Hang Seng index in Hong Kong is up 0.1%.

Brent oil was quoted at USD59.93 a barrel, up from USD59.62 a barrel at the London equities close Friday. Gold fetched USD1,816.77 an ounce, up from USD1,808.40.

By Eric Cunha; ericcunha@alliancenews.com;

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
Today 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
Today 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
Today 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
Today 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
Today 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
Today 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
Today 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
Today 06:30

Sanofi Q1 profit slips on generic competition, forex effects

April 25 (Reuters) - Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.